Twenty four asymptomatic HAART-treated HIV-1 + patients were enrolled in a phase I clinical study and were randomized to three groups : 2 groups were treated with five IM injection ( Arm A : 25g/inoculation ; Arm B : 100g/inoculation ) at day ( D ) D0 , D28 , D56 , D84 and D112 ; the control group ( Arm C ) were not injected .